TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Non-Current Assets came in at $22.3 million in Q1 2026, down 13.24% YoY from $25.7 million in Q1 2025, and down 3.85% on a QoQ basis from $23.2 million in Q4 2025.
TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Non-Current Assets data on file, last reported at $22.3 million in Q1 2026.
- Quarterly Non-Current Assets fell 13.24% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.7 million (down 12.27% YoY) and the FY2025 annual result came in at $23.2 million, down 12.62% from the prior year.
- Non-Current Assets declined to $22.3 million in Q1 2026, from $23.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $49.0 million in Q1 2022 to a low of $22.3 million in Q1 2026.
- A 5-year average of $32.1 million and a median of $30.6 million in 2024 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 6.33% in 2022, down 29.79% in 2022.
- Tracing TXMD's Non-Current Assets over 5 years: stood at $35.1 million in 2022, then decreased by 10.24% to $31.5 million in 2023, then slipped by 15.71% to $26.6 million in 2024, then retreated by 12.62% to $23.2 million in 2025, then slipped by 3.85% to $22.3 million in 2026.
- The last three Non-Current Assets figures came in at $22.3 million (Q1 2026), $23.2 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.41 Mn |
| Mar 31, 2026 | 22.32 Mn |
| Dec 31, 2025 | 23.21 Mn |
| Sep 30, 2025 | 24.17 Mn |
| Jun 30, 2025 | 25.04 Mn |
| Mar 31, 2025 | 25.72 Mn |
| Dec 31, 2024 | 26.56 Mn |
| Sep 30, 2024 | 27.40 Mn |
| Jun 30, 2024 | 28.30 Mn |
| Mar 31, 2024 | 30.57 Mn |
| Dec 31, 2023 | 31.51 Mn |
| Sep 30, 2023 | 33.05 Mn |
| Jun 30, 2023 | 34.08 Mn |
| Mar 31, 2023 | 34.87 Mn |
| Dec 31, 2022 | 35.11 Mn |
| Sep 30, 2022 | 46.43 Mn |
| Jun 30, 2022 | 47.60 Mn |
| Mar 31, 2022 | 48.96 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Sep 30, 2021 | 49.65 Mn |